Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C. and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Boudadi is board certified in medical oncology, hematology, and internal medicine by the American Board of Internal Medicine.
Dr. Boudadi has expertise in treating a wide range of cancers such as cancers of the head and neck, cancers of the esophagus, bone and soft tissue sarcomas, and prostate cancer. Having completed dual training in medical oncology and hematology at Johns Hopkins, Dr. Boudadi also sees patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders and clotting disorders.
Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy.
Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine.
Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy.